FDA in Turmoil After Exit of Veteran Cancer Researcher
Pazdur’s retirement highlights tensions over political influence and drug review speed, raising concerns about FDA’s safety standards amid leadership turnover, sources say.
9 Articles
9 Articles
FDA in turmoil after exit of veteran cancer researcher
Food and Drug Administration Commissioner Marty Makary is under renewed scrutiny by Trump officials amid continued turmoil at the agency, including a series of high-profile departures that have raised questions in the administration about Makary’s ability to lead, according to two people familiar with conversations.
Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations BIO calls for the end of “constant turmoil,” urges the administration to “right the ship”
After three weeks of brutal combat, Richard Pazdur decided that he has had enough. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site and log in/register to read.The post Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations appeared first o…
Coverage Details
Bias Distribution
- 72% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium






